Workshop report: Malaria vaccine development in Europe–preparing for the future

Abstract The deployment of a safe and effective malaria vaccine will be an important tool for the control of malaria and the reduction in malaria deaths. With the launch of the 2030 Malaria Vaccine Technology Roadmap, the malaria community has updated the goals and priorities for the development of...

Full description

Saved in:
Bibliographic Details
Published inVaccine Vol. 33; no. 46; pp. 6137 - 6144
Main Authors Viebig, Nicola K, D’Alessio, Flavia, Draper, Simon J, Sim, B. Kim Lee, Mordmüller, Benjamin, Bowyer, Paul W, Luty, Adrian J.F, Jungbluth, Stefan, Chitnis, Chetan E, Hill, Adrian V.S, Kremsner, Peter, Craig, Alister G, Kocken, Clemens H.M, Leroy, Odile
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ltd 17.11.2015
Elsevier Limited
Subjects
Allergy and Immunology
Antigen discovery
Capacity building
Controlled human malaria infection
Correlates of protection
Drug Discovery - methods
Drug Discovery - trends
Education
Global Health
Good Manufacturing Practice
Humans
Malaria
Malaria Vaccines - immunology
Malaria Vaccines - isolation & purification
Parasites
Pharmaceutical industry
R&D
Research & development
Vaccine
Vaccines
Vector-borne diseases
North America
Africa
Vaccine
Capacity building
Correlates of protection
Malaria
Controlled human malaria infection
Antigen discovery
Online AccessGet full text

Cover

More Information
Summary:Abstract The deployment of a safe and effective malaria vaccine will be an important tool for the control of malaria and the reduction in malaria deaths. With the launch of the 2030 Malaria Vaccine Technology Roadmap, the malaria community has updated the goals and priorities for the development of such a vaccine and is now paving the way for a second phase of malaria vaccine development. During a workshop in Brussels in November 2014, hosted by the European Vaccine Initiative, key players from the European, North American and African malaria vaccine community discussed European strategies for future malaria vaccine development in the global context. The recommendations of the European malaria community should guide researchers, policy makers and funders of global health research and development in fulfilling the ambitious goals set in the updated Malaria Vaccine Technology Roadmap.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2015.09.074